Subscribe

SETO Holdings, Inc. (SETO)

USD0.01 +0.00 (+0.00%)
US OTC Healthcare Medical - Care Facilities
Address 7476 New Ridge Road 21076
Hanover, MD, US
CEO Janon Costley
IPO 1998-10-08
ISIN US8178131087

Explore sections of this company profile

Description

SETO Holdings, Inc. is an emerging enterprise primarily focused on providing healthcare services. In the United States, its Health division delivers a variety of medical services across the Mid-Atlantic region. The company is currently engaged in establishing a surgical center in Maryland and plans to open four new diabetes clinics by utilizing its existing sites and collaborating with other health professionals. Complementing its general health offerings, SETO Holdings also operates a Hearing Care Group, which manages fifteen specialized clinics offering audiology services throughout the Mid-Atlantic. Furthermore, the company is involved in a significant international initiative, assisting in the development of a hospital facility in India. SETO Holdings was established in 2004 and is headquartered in Hanover, Maryland.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD0.01 +0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
6.8K
Free Float %
0.0%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+4.76% -41.49% +10.00% -0.90% +57.14% -23.61% -60.00% +120.00% -31.25% -8.33% -95.77%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
0.01
DCF (Unlevered) 0.04 +151.6%
DCF (Levered) 0.02 +46.0%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM)
Rating 2024-11 Change
Strong Buy 0 0
Buy 0 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
-26.59
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Care Facilities: +10.2%
  • EPS growth Medical - Care Facilities: +19.2%
    +99.5% Q4'25: +100.0% (vs Q4'24)
  • FCF margin FCF growth · Medical - Care Facilities: +32.0%
    -31.6% Q4'25: -2.8% (vs Q4'24)
  • EBIT margin Medical - Care Facilities: +11.3%
    -62.5% Q4'25: +31.4% (vs Q4'24)
  • ROIC Medical - Care Facilities: +6.8%
    -10.6% Q4'25: +17.1% (vs Q4'24)
  • Share dilution Medical - Care Facilities: +0.0%
    +17.5% Q4'25: +17.5% (vs Q4'24)
  • Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×
    -0.51× Q4'25: -0.18× (vs Q4'24)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.00) × ERP
WACC = 86% × Ke + 14% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 0.04 Current price: 0.01
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-21 B 3/5 5/5 1/5 1/5 3/5 1/5 5/5
2026-05-01 B- 3/5 4/5 1/5 1/5 3/5 1/5 5/5
2026-04-29 B- 3/5 5/5 1/5 1/5 2/5 1/5 5/5
2026-04-27 B- 3/5 5/5 1/5 1/5 2/5 1/5 5/5
2026-04-22 B- 3/5 5/5 1/5 1/5 2/5 1/5 5/5
2026-04-21 B- 2/5 4/5 1/5 1/5 2/5 1/5 5/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
19.1K
OE per share TTM
0.00
Owner's Yield
1.46%
Maintenance CapEx ratio
35.17%
Maint CapEx / Avg PPE
11.2%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
-205.9K
Shares Outstanding
12.47M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Janon Costley President, CEO & Director male
Ryan Thomas Dolder COO, CFO, Secretary, Treasurer & Director male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings reports

Stock splits